Advertisement
Breast cancer screening guidelines spark a racial divide

Breast cancer screening guidelines spark a racial divide

By Sabriya Rice and Steven Ross Johnson  |  May 07, 2016

Some health and civil-rights advocates say guidelines that recommend women postpone breast cancer screenings until they are age 50 should not apply to black women, who are more likely to die if they contract the disease.

Providers invest in next frontier of patient genetic data

Providers invest in next frontier of patient genetic data

By Beth Kutscher  |  May 07, 2016

As providers are tasked with keeping people healthy through risk-based payment contracts, they're investing in genomics and personalized medicine in order to develop new methods of targeting patients who need early intervention.

Q&A: American public's confidence in the FDA must be ensured

Q&A: American public's confidence in the FDA must be ensured

By Modern Healthcare  |  April 02, 2016

Dr. Robert Califf became commissioner of the FDA in February. He brings to the job more than 30 years of experience in clinical trial research at Duke University Medical Center. Califf discusses his priorities and some of the controversies that swirled around his nomination.

Large cancer-care provider settles over radiation testing

By Lisa Schencker  |  March 03, 2016

Cancer treatment provider 21st Century Oncology will settle with the federal government to end a dispute related to its radiation therapy testing, a company spokeswoman confirmed Thursday. It's the company's second settlement in three months.

Blog: Quality of ovarian cancer care varies considerably

By Sabriya Rice  |  March 02, 2016

There is “considerable variability,” and one of the most significant factors affecting quality of care is whether a patient is treated by a gynecologic oncologist at a high-volume facility, according to the report from the National Academies of Sciences, Engineering, and Medicine.

McKesson pays $1.2 billion for oncology provider and specialty pharmacy

By Adam Rubenfire  |  February 25, 2016

McKesson announced Thursday that it had acquired two oncology companies to bolster its specialty health segment. The combined transactions were valued at $1.2 billion, and are expected to close in the first quarter of fiscal 2017, pending customary closing conditions.

War on cancer, take two

War on cancer, take two

By Maria Castellucci and Sabriya Rice  |  January 16, 2016

In light of the challenges seen since President Nixon launched the first "war on cancer" in 1971, experts say any new approach to cures, moonshot or otherwise, must get back to the basics. The oncology community agrees a coordinated approach could address the clinical research challenges.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.